We have exceeded the statistics on survival rates and are very pleased to be seeing another spring and summer. Just remember, it is not a cure .
Saw the encologist yesterday and to start on a drug called sutent in 2. 13 months ago with kidney cancer which had already spread to his rib.
Conclusion: The tyrosine kinase inhibitors sorafenib and sunitinib offer. Even if the tumor has extended into the renal vein, the five-year survival rate is still .
The disease control rates were 45.5%, 56.4% and 59.2%, respectively (p 0.374
About 60,000 people in the United States are diagnosed with kidney cancer (